SOLV Solventum Corporation
Healthcare$76.27-0.73%ClosedMarket Cap: $13.21B
As of 2026-05-26
Valuation
P/E (TTM)
6.97
PEG
0.03
P/B
2.69
P/S
1.61
EV/EBITDA
6.46
DCF Value
$153.32
FCF Yield
-1.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
53.7%
Operating Margin
25.5%
Net Margin
17.3%
ROE
30.7%
ROA
10.2%
ROIC
15.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $2.01B | 54.7% | $81.0M | $13.0M | $— | — |
| Q4 null | $2.00B | 49.3% | $1.68B | $63.0M | $— | — |
| FY null | $8.32B | 53.5% | $2.18B | $1.56B | $— | — |
| Q3 null | $2.10B | 56.2% | $137.0M | $1.27B | $— | — |
| Q2 null | $2.16B | 54.4% | $214.0M | $90.0M | $— | — |
| Q1 null | $2.07B | 53.8% | $152.0M | $137.0M | $— | — |
| Q4 null | $2.08B | 53.9% | $136.0M | $31.0M | $— | — |
| FY null | $8.25B | 55.6% | $1.04B | $479.0M | $— | — |
| Q3 null | $2.08B | 56.0% | $275.0M | $122.0M | $— | — |
| Q2 null | $2.08B | 54.6% | $244.0M | $89.0M | $— | — |
| Q1 null | $2.02B | 58.1% | $381.0M | $237.0M | $— | — |
| Q4 2023 | $2.04B | 56.9% | $406.0M | $272.0M | $1.57 | — |